On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The new Learning Center website launch today on Monday, March 30, 2020. While the link to the new Le...
On September 14, 2020, our Phoenix laboratory began performing a portion of our alternate donor anti...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA test...
Celebrate National Blood Donor Month throughout January by inviting eligible individuals to donate b...